| Warren C Botnick, MD | |
|
601 Keyser Ave, Natchitoches, LA 71457-6020 | |
| (318) 214-5770 | |
| Not Available |
| Full Name | Warren C Botnick |
|---|---|
| Gender | Male |
| Speciality | Pulmonary Disease |
| Experience | 38 Years |
| Location | 601 Keyser Ave, Natchitoches, Louisiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1750382339 | NPI | - | NPPES |
| 000862738B | Medicaid | GA |
| Facility Name | Location | Facility Type |
|---|---|---|
| Natchitoches Regional Medical Center | Natchitoches, LA | Hospital |
| Tristar Skyline Medical Center | Nashville, TN | Hospital |
| Christus St Frances Cabrini Hospital | Alexandria, LA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Nrmc Physician Ipa Inc | 9234400300 | 20 |
| Middle Tennessee Pulmonary Associates Llc | 8628090958 | 28 |
News Archive
Santarus, Inc., a specialty biopharmaceutical company, today announced the completion of enrollment of 510 patients in a U.S. Phase III clinical study to evaluate budesonide MMX® administered over eight weeks for the induction of remission of mild or moderate active ulcerative colitis. This is the second Phase III clinical study being conducted in collaboration with Cosmo Technologies Ltd., a subsidiary of Cosmo Pharmaceuticals SpA, as part of the budesonide MMX Phase III clinical program for U.S. registration.
San Francisco-based Dicom Systems has unveiled the latest fully automated feature of its DCMSYS router, further improving the effectiveness of its groundbreaking DICOM Systems Router product line, DCMSYS.
Changing the texture and surface characteristics of a semiconductor material at the nanoscale can influence the way that neural cells grow on the material.
Scientists at La Jolla Institute for Immunology (LJI) have published a detailed map of where human antibodies bind to SARS-CoV-2, a map that was generated by a global collaboration comparing nearly all leading clinical candidates.
› Verified 8 days ago
| Entity Name | Natchitoches Medical Specialists |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1124257530 PECOS PAC ID: 5395889927 Enrollment ID: O20100221000012 |
News Archive
Santarus, Inc., a specialty biopharmaceutical company, today announced the completion of enrollment of 510 patients in a U.S. Phase III clinical study to evaluate budesonide MMX® administered over eight weeks for the induction of remission of mild or moderate active ulcerative colitis. This is the second Phase III clinical study being conducted in collaboration with Cosmo Technologies Ltd., a subsidiary of Cosmo Pharmaceuticals SpA, as part of the budesonide MMX Phase III clinical program for U.S. registration.
San Francisco-based Dicom Systems has unveiled the latest fully automated feature of its DCMSYS router, further improving the effectiveness of its groundbreaking DICOM Systems Router product line, DCMSYS.
Changing the texture and surface characteristics of a semiconductor material at the nanoscale can influence the way that neural cells grow on the material.
Scientists at La Jolla Institute for Immunology (LJI) have published a detailed map of where human antibodies bind to SARS-CoV-2, a map that was generated by a global collaboration comparing nearly all leading clinical candidates.
› Verified 8 days ago
| Entity Name | Nrmc Physician Ipa Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497283733 PECOS PAC ID: 9234400300 Enrollment ID: O20170808001651 |
News Archive
Santarus, Inc., a specialty biopharmaceutical company, today announced the completion of enrollment of 510 patients in a U.S. Phase III clinical study to evaluate budesonide MMX® administered over eight weeks for the induction of remission of mild or moderate active ulcerative colitis. This is the second Phase III clinical study being conducted in collaboration with Cosmo Technologies Ltd., a subsidiary of Cosmo Pharmaceuticals SpA, as part of the budesonide MMX Phase III clinical program for U.S. registration.
San Francisco-based Dicom Systems has unveiled the latest fully automated feature of its DCMSYS router, further improving the effectiveness of its groundbreaking DICOM Systems Router product line, DCMSYS.
Changing the texture and surface characteristics of a semiconductor material at the nanoscale can influence the way that neural cells grow on the material.
Scientists at La Jolla Institute for Immunology (LJI) have published a detailed map of where human antibodies bind to SARS-CoV-2, a map that was generated by a global collaboration comparing nearly all leading clinical candidates.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Warren C Botnick, MD Po Box 2475, Natchitoches, LA 71457-2475 Ph: (318) 214-5770 | Warren C Botnick, MD 601 Keyser Ave, Natchitoches, LA 71457-6020 Ph: (318) 214-5770 |
News Archive
Santarus, Inc., a specialty biopharmaceutical company, today announced the completion of enrollment of 510 patients in a U.S. Phase III clinical study to evaluate budesonide MMX® administered over eight weeks for the induction of remission of mild or moderate active ulcerative colitis. This is the second Phase III clinical study being conducted in collaboration with Cosmo Technologies Ltd., a subsidiary of Cosmo Pharmaceuticals SpA, as part of the budesonide MMX Phase III clinical program for U.S. registration.
San Francisco-based Dicom Systems has unveiled the latest fully automated feature of its DCMSYS router, further improving the effectiveness of its groundbreaking DICOM Systems Router product line, DCMSYS.
Changing the texture and surface characteristics of a semiconductor material at the nanoscale can influence the way that neural cells grow on the material.
Scientists at La Jolla Institute for Immunology (LJI) have published a detailed map of where human antibodies bind to SARS-CoV-2, a map that was generated by a global collaboration comparing nearly all leading clinical candidates.
› Verified 8 days ago
Dr. Alfred Godwin Ajise, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 90 Melrose Ave, Natchitoches, LA 71457 Phone: 318-238-3820 Fax: 318-238-3823 | |
Dr. James Paul Thibodaux Jr., MD Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 1055 Parkway Dr Ste A, Natchitoches, LA 71457 Phone: 318-352-6464 Fax: 318-352-2488 | |
Mrs. Kathleen Edna Kautz, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1029 Keyser Avenue, Natchitoches, LA 71457 Phone: 318-238-6001 Fax: 318-238-6002 | |
Oluwatoyin Funmilayo Olatinwo, M.D. Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 740 Keyser Ave, Suite F, Natchitoches, LA 71457 Phone: 318-238-5050 Fax: 318-238-5052 | |
Otis R Barnum, DO Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 617 Bienville St, Natchitoches, LA 71457 Phone: 318-352-9880 Fax: 318-357-1347 | |
Mr. Stephen W Wheat, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 138 East 5th Street, Suite E, Natchitoches, LA 71457 Phone: 318-352-4477 Fax: 318-352-4470 | |
Dr. Christopher L Ingram, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 501 Keyser Ave, Natchitoches, LA 71457 Phone: 318-214-4550 Fax: 318-214-4553 |